U.S. Physical Therapy, Inc. (NYSE:USPH) Plans Quarterly Dividend of $0.45

U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) declared a quarterly dividend on Wednesday, February 26th, NASDAQ Dividends reports. Stockholders of record on Friday, March 14th will be paid a dividend of 0.45 per share on Friday, April 11th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.27%. The ex-dividend date of this dividend is Friday, March 14th.

U.S. Physical Therapy has increased its dividend payment by an average of 6.4% annually over the last three years. U.S. Physical Therapy has a payout ratio of 61.2% meaning its dividend is sufficiently covered by earnings. Research analysts expect U.S. Physical Therapy to earn $2.93 per share next year, which means the company should continue to be able to cover its $1.80 annual dividend with an expected future payout ratio of 61.4%.

U.S. Physical Therapy Stock Performance

Shares of USPH stock traded down $1.74 during mid-day trading on Monday, reaching $79.28. The stock had a trading volume of 61,280 shares, compared to its average volume of 99,784. The business's fifty day moving average is $88.20 and its 200-day moving average is $87.65. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The firm has a market cap of $1.20 billion, a price-to-earnings ratio of 84.39, a PEG ratio of 3.54 and a beta of 1.48. U.S. Physical Therapy has a 1-year low of $76.18 and a 1-year high of $113.63.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing analysts' consensus estimates of $0.69 by ($0.04). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The company had revenue of $180.45 million during the quarter, compared to analysts' expectations of $173.10 million. On average, research analysts forecast that U.S. Physical Therapy will post 2.67 earnings per share for the current year.

Remove Ads

Insider Transactions at U.S. Physical Therapy

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of U.S. Physical Therapy stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $96.25, for a total transaction of $49,665.00. Following the completion of the sale, the chief financial officer now directly owns 20,469 shares of the company's stock, valued at $1,970,141.25. The trade was a 2.46 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 1.70% of the company's stock.

Analyst Ratings Changes

Several equities analysts have recently weighed in on USPH shares. JMP Securities started coverage on U.S. Physical Therapy in a research report on Monday, December 16th. They issued an "outperform" rating and a $113.00 target price on the stock. Citizens Jmp upgraded U.S. Physical Therapy to a "strong-buy" rating in a research report on Monday, December 16th. William Blair restated a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday. JPMorgan Chase & Co. raised their target price on U.S. Physical Therapy from $117.00 to $120.00 and gave the company an "overweight" rating in a research report on Tuesday, December 3rd. Finally, Bank of America raised U.S. Physical Therapy from a "neutral" rating to a "buy" rating and increased their price target for the company from $100.00 to $115.00 in a report on Monday, December 16th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, four have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $111.50.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.